Vaccination against human papillomavirus (HPV) is recommended for young adolescents (middle school students) before the start of their sexual life to ensure optimal efficacy in the prevention of numerous cancers.

noli's read

This advice is based on a robust scientific consensus. The literature, notably meta-analyses published in The Lancet, confirms that vaccination before exposure to the virus is extremely effective in preventing persistent infections and precancerous lesions (level of evidence: meta-analysis/public health data). The temporal argument is validated: efficacy decreases after prior exposure to the virus, as the vaccine is preventive and not curative. There is no exaggeration here; global health authorities, such as the WHO and Santé Publique France, support this strategy to reduce the incidence of ENT and gynecological cancers. The collective benefit is also demonstrated by a significant reduction in circulating viral strains in populations with high vaccination coverage rates. The information is therefore perfectly aligned with the current state of science.

the sources

No named source held this one up — that absence is part of the verdict.